Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gillespie

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 18, 2022
Understanding the support experiences of families of children with autism and sensory processing difficulties: A qualitative studySarah Milosevic, Lucy Brookes-Howell, Elizabeth Randell, et al.
BMJ Open|February 22, 2022
Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10-14 year-olds: a pragmatic randomised controlled trialJeremy Segrott, David Gillespie, Mandy Lau, et al.
Diagnostic Microbiology and Infectious Disease|August 20, 2013
Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional cerebrospinal fluid (CSF) cultures among children undergoing treatment for CSF shunt infectionTamara D Simon, Brian Van Yserloo, Kevin Nelson, et al.
British Journal of Health Psychology|November 7, 2025
Are you afraid of COVID-19? Motivation and engagement in infection-prevention behaviour in a UK community cohort during the first 2 years of the COVID-19 pandemicRhiannon Phillips, Britt Hallingberg, Anna Torrens-Burton, et al.
Journal of Cardiovascular Pharmacology|December 9, 2025
Ivabradine as a treatment for postural orthostatic tachycardia syndrome: A systematic reviewChun Shing Kwok, David Gillespie, Naeem Ur Rehman Qazi, et al.
BMC Public Health|January 21, 2014
Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10-14 UK (SFP 10-14 UK)Jeremy Segrott, David Gillespie, Jo Holliday, et al.
SSM - Population Health|January 6, 2018
An application of Extended Normalisation Process Theory in a randomised controlled trial of a complex social intervention: Process evaluation of the Strengthening Families Programme (10-14) in Wales, UKJeremy Segrott, Simon Murphy, Heather Rothwell, et al.
BMC Health Services Research|January 14, 2021
A multi-stakeholder approach to the co-production of the research agenda for medicines optimisationJohn Fellenor, Nicky Britten, Molly Courtenay, et al.
The Journal of Biological Chemistry|January 9, 2008
c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21Tim H Holmström, Antoine Mialon, Marko Kallio, et al.
BMJ Open|October 8, 2020
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infantsJohn Lowe, David Gillespie, Marie Hubbard, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 18, 2022
Understanding the support experiences of families of children with autism and sensory processing difficulties: A qualitative studySarah Milosevic, Lucy Brookes-Howell, Elizabeth Randell, et al.
BMJ Open|February 22, 2022
Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10-14 year-olds: a pragmatic randomised controlled trialJeremy Segrott, David Gillespie, Mandy Lau, et al.
Diagnostic Microbiology and Infectious Disease|August 20, 2013
Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional cerebrospinal fluid (CSF) cultures among children undergoing treatment for CSF shunt infectionTamara D Simon, Brian Van Yserloo, Kevin Nelson, et al.
British Journal of Health Psychology|November 7, 2025
Are you afraid of COVID-19? Motivation and engagement in infection-prevention behaviour in a UK community cohort during the first 2 years of the COVID-19 pandemicRhiannon Phillips, Britt Hallingberg, Anna Torrens-Burton, et al.
Journal of Cardiovascular Pharmacology|December 9, 2025
Ivabradine as a treatment for postural orthostatic tachycardia syndrome: A systematic reviewChun Shing Kwok, David Gillespie, Naeem Ur Rehman Qazi, et al.
BMC Public Health|January 21, 2014
Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10-14 UK (SFP 10-14 UK)Jeremy Segrott, David Gillespie, Jo Holliday, et al.
SSM - Population Health|January 6, 2018
An application of Extended Normalisation Process Theory in a randomised controlled trial of a complex social intervention: Process evaluation of the Strengthening Families Programme (10-14) in Wales, UKJeremy Segrott, Simon Murphy, Heather Rothwell, et al.
BMC Health Services Research|January 14, 2021
A multi-stakeholder approach to the co-production of the research agenda for medicines optimisationJohn Fellenor, Nicky Britten, Molly Courtenay, et al.
The Journal of Biological Chemistry|January 9, 2008
c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21Tim H Holmström, Antoine Mialon, Marko Kallio, et al.
BMJ Open|October 8, 2020
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infantsJohn Lowe, David Gillespie, Marie Hubbard, et al.
Pageof 17